» Articles » PMID: 17415794

Developmental Effects of +/-3,4-methylenedioxymethamphetamine on Spatial Versus Path Integration Learning: Effects of Dose Distribution

Overview
Journal Synapse
Specialty Neurology
Date 2007 Apr 7
PMID 17415794
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We previously demonstrated that postnatal day 11-20 +/-3,4-methylenedioxymethamphetamine (MDMA) exposure reduces locomotor activity and impairs path integration and spatial learning independent of the effects on activity. The effects were seen when the drug was administered twice per day, but the optimal dosing regimen is unknown. We tested whether the same total daily dose of MDMA administered in different patterns would equally affect later behavior. A split-litter design (15 litters) was used with one male/female pair per litter receiving one of four treatment regimens. All offspring received four injections per day on P11-20 as follows: 40 x 1 (40 mg/kg MDMA x 1 + saline x 3), 20 x 2 (20 mg/kg MDMA x 2 + saline x 2), 10 x 4 (10 mg/kg MDMA x 4), or Saline (saline x 4). Doses were spaced 2 h apart. Group 40 x 1 received MDMA as the first daily dose followed by three saline doses; group 20 x 2 received MDMA as the first and last dose and saline for the middle two doses; group 10 x 4 received MDMA for all four doses; and the saline group received saline for all four doses. Regardless of dose schedule, all groups treated with MDMA exhibited reduced locomotor activity. No MDMA effects were found on swimming ability in a straight channel. Modest MDMA effects were found on Barnes maze performance. The major findings were that the 40 x 1 and 20 x 2 MDMA groups showed impaired Cincinnati multiple T-water-maze learning and the 10 x 4 and 20 x 2 MDMA groups showed impaired Morris water maze learning. The results suggest that MDMA dose distribution has a long-term differential effect on different types of learning. Dose distribution warrants greater attention in the design of developmental drug studies along with the standard considerations of dose and age.

Citing Articles

A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Chaliha D, Mamo J, Albrecht M, Lam V, Takechi R, Vaccarezza M Curr Neuropharmacol. 2021; 19(7):1101-1154.

PMID: 33388021 PMC: 8686313. DOI: 10.2174/1570159X19666210101130258.


Cincinnati water maze: A review of the development, methods, and evidence as a test of egocentric learning and memory.

Vorhees C, Williams M Neurotoxicol Teratol. 2016; 57:1-19.

PMID: 27545092 PMC: 5056837. DOI: 10.1016/j.ntt.2016.08.002.


Hippocampal 5-HT1A Receptor and Spatial Learning and Memory.

Glikmann-Johnston Y, Saling M, Reutens D, Stout J Front Pharmacol. 2015; 6:289.

PMID: 26696889 PMC: 4674558. DOI: 10.3389/fphar.2015.00289.


Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Graham D, Herring N, Schaefer T, Holland K, Vorhees C, Williams M Open Neuropsychopharmacol J. 2015; 5:1-8.

PMID: 25995775 PMC: 4435606. DOI: 10.2174/1876523801205010001.


Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine.

Williams M, Skelton M, Longacre I, Huggins K, Maple A, Vorhees C Toxicol Rep. 2014; 1:699-706.

PMID: 25419515 PMC: 4235131. DOI: 10.1016/j.toxrep.2014.08.018.


References
1.
McElhatton P, Bateman D, Evans C, Pughe K, Thomas S . Congenital anomalies after prenatal ecstasy exposure. Lancet. 1999; 354(9188):1441-2. DOI: 10.1016/s0140-6736(99)02423-x. View

2.
Clancy B, Kersh B, Hyde J, Darlington R, Anand K, Finlay B . Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics. 2007; 5(1):79-94. DOI: 10.1385/ni:5:1:79. View

3.
Rice D, Barone Jr S . Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000; 108 Suppl 3:511-33. PMC: 1637807. DOI: 10.1289/ehp.00108s3511. View

4.
Clark R, Zola S, Squire L . Impaired recognition memory in rats after damage to the hippocampus. J Neurosci. 2000; 20(23):8853-60. PMC: 6773055. View

5.
Broening H, Morford L, Fukumura M, Vorhees C . 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci. 2001; 21(9):3228-35. PMC: 6762552. View